4368 — Fuso Chemical Co Balance Sheet
0.000.00%
- ¥428bn
- ¥404bn
- ¥77bn
Annual balance sheet for Fuso Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 24,360 | 23,413 | 31,472 | 31,296 | 41,007 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 14,873 | 14,954 | 16,445 | 16,031 | 18,233 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 52,078 | 55,344 | 68,134 | 67,052 | 78,476 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 35,291 | 54,302 | 59,027 | 66,983 | 64,540 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 92,010 | 113,529 | 133,740 | 141,502 | 152,256 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 14,667 | 23,909 | 16,457 | 18,490 | 19,844 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 16,706 | 26,026 | 38,715 | 37,453 | 35,039 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 75,303 | 87,503 | 95,025 | 104,049 | 117,217 |
| Total Liabilities & Shareholders' Equity | 92,010 | 113,529 | 133,740 | 141,502 | 152,256 |
| Total Common Shares Outstanding |